Aspirin Suppository shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2026-07-23 · last update 2026-07-23
Manufacturers: Padagis US LLC
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Aspirin, Suppository, 300 mg (NDC 0574-7034-12) | Padagis US LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 07/23/2026 Updated 07/23/2026 Discontinued 07/23/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)